Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goserelin for Ovarian Protection in Breast Cancer Chemotherapy
NCT01530607Phase 3Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Nov 2009
- Primary completion
- Nov 2012
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 3 trial of goserelin in primary ovarian insufficiency (POI), sponsored by King Faisal Specialist Hospital and Research Centre. Started Nov 2009; status: completed.
02
Drugs
goserelin
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT01530607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01530607.